TRxADE HEALTH shares are trading higher after Superlatus, which recently merged with the company, acquired The Urgent Company.
Portfolio Pulse from Benzinga Newsdesk
TRxADE HEALTH's shares are trading higher following the acquisition of The Urgent Company by Superlatus, which recently merged with TRxADE HEALTH.
August 22, 2023 | 4:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TRxADE HEALTH (MEDS) shares are likely to experience a short-term boost due to the acquisition of The Urgent Company by Superlatus, a recent merger partner.
The acquisition of The Urgent Company by Superlatus, which recently merged with TRxADE HEALTH, is likely to bring additional resources and capabilities to the company. This could potentially lead to increased investor confidence and a short-term boost in the company's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100